Definitive Contract 75N91023C00026

Award Date 8/10/23
Potential Completion Date 8/9/24
Potential Value $400K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21205, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $354,415.00 Firm Fixed Price contract to Oncospace Inc., a Baltimore-based small business, to develop artificial intelligence (AI) tools to understand and duplicate expert radiation therapy planning for prostate cancer. This contract is part of the Small Business Innovation Research (SBIR) program and builds upon prior SBIR and National Science Foundation awards to Oncospace Inc....
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This is a $398,604.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded to Infotech Soft, Inc. (a woman-owned for-profit organization) by the National Cancer Institute. The contract is for the development of quantitative imaging software tools to assist with cancer diagnosis and treatment planning. The contract is a definitive, firm fixed-price agreement, indicating a well-defined scope of work. This SBIR award is part of the National Cancer Institute's efforts to...
This definitive contract was awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to Intelligent Automation, LLC. The $399,980 firm fixed price contract is for Phase I of the SBIR program's TOPIC 412, which seeks the development of a wearables-agnostic platform for continuous health monitoring and predictions to support cancer patients. The one-year period of performance will take place in Derwood,...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Intelligent Automation, LLC, a small business. The contract is for the development of a Mobile PRO-CTCAE Administration System for Post-Radiation Toxicities, with a potential value of $224,995.00. The contract is a Firm Fixed Price Definitive Contract. Intelligent Automation has previously received SBIR Phase III awards from the U.S. Air Force for...
This is a $398,714 firm fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Irai Technologies, LLC, a minority-owned small business. The contract is for the development of a flash dosimetry system based on ionizing radiation acoustic imaging, under Solicitation PHS-2023-1 for the NIH and CDC SBIR program. The goal is to contribute toward NCI mission needs and SBIR program objectives by stimulating technological innovation and fostering participation from small,...

This SBIR Phase I contract award of $399,870 to Oncospace Inc. will fund research and development of a software tool for standardizing radiotherapy treatment plans to support artificial intelligence validation. The contract responds to National Institutes of Health National Cancer Institute SBIR Topic 454 and will take place over one year in Baltimore, Maryland. It was awarded under the NIH/CDC SBIR solicitation seeking innovative solutions across over 125 topics related to cancer treatment, infectious diseases, aging, and public health. As a total small business set-aside, this award furthers the solicitation's goal of supporting small businesses through the NIH and CDC's missions in biomedical and public health research.

Generated 12/29/23, 5:00 PM